SEC Form 4 · accession 0001127602-18-009704
CVS HEALTH Corp · CVS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas M Moriarty
Officer — EVP & General Counsel
Period of report
Feb 28, 2018
Accepted (ET)
Mar 2, 2018 · 4:42 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000064803
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Stock UnitF1 | Feb 28, 2018 | A | 4,650 | $67.73 | A | 41,371 | D | |
| Common Stock | holding | — | — | — | 22,640 | D | ||
| Common Stock (restricted) | holding | — | — | — | 43,668 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Consists of Stock Units awarded at market price pursuant to Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan, the receipt of which the reporting person has elected to defer.